{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:34:57Z","timestamp":1787168097402,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.eplepsyres.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T17:45:13Z","timestamp":1342892713000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy"],"prefix":"10.1016","volume":"102","author":[{"given":"Vincenzo","family":"Belcastro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","article-title":"Antiepileptic drugs as independent predictors of plasma total homocysteine levels","volume":"47","author":"Apeland","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-1211(02)00153-5","article-title":"The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs","volume":"51","author":"Apeland","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0015","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.0b013e3182152844","article-title":"Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children","volume":"76","author":"Arya","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eplepsyres.2006.06.015","article-title":"Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy","volume":"71","author":"Attilakos","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12017-009-8110-1","article-title":"Homocysteine potentiates seizures and cell loss induced by pilocarpine treatment","volume":"12","author":"Baldelli","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/pds.2271","article-title":"Vascular risk in epilepsy patients: is antiepileptic treatment the key?","volume":"21","author":"Belcastro","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0035","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1528-1167.2007.01164.x","article-title":"Antiepileptic drugs and MTHFR polymorphisms influence hyperhomocysteinemia recurrence in epileptic patients","volume":"48","author":"Belcastro","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2008.04.008","article-title":"Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy","volume":"81","author":"Belcastro","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0045","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/eye.2008.326","article-title":"Is retinal assessment useful in epileptic patients with hyperhomocysteinemia?","volume":"23","author":"Belcastro","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1528-1167.2009.02303.x","article-title":"Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs","volume":"51","author":"Belcastro","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.seizure.2012.01.013","article-title":"The effect of vitamin B supplementation on homocysteinemetabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid","volume":"21","author":"Bochy\u0144ska","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0060","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/NMM:6:2-3:117","article-title":"Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia","volume":"6","author":"Caccamo","year":"2004","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0070","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0002-9394(03)00571-3","article-title":"Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease","volume":"136","author":"Cahill","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1017\/S0007114500000751","article-title":"The effect of 677CT and 1298AC mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects","volume":"83","author":"Chango","year":"2000","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0085","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(04)15946-1","article-title":"Late-onset seizures as a predictor of subsequent stroke","volume":"10","author":"Cleary","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0090","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0140-6736(94)92270-5","article-title":"Mortality from epilepsy: results from a prospective population-based study","volume":"344","author":"Cockerell","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.seizure.2012.02.011","article-title":"Role of folic acid depletion on homocysteine serum level in children and adolescents with epilepsy and different MTHFR C677T genotypes","volume":"21","author":"Coppola","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0100","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJM200405203502120","article-title":"Folic acid and the prevention of neural-tube defects","volume":"350","author":"Czeizel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","article-title":"Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomized, double blind, controlled trial","volume":"369","author":"Durga","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2007.07.005","article-title":"Cardiovascular risk factors and homocysteine in epilepsy","volume":"76","author":"Elliott","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.braindev.2008.11.001","article-title":"Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid","volume":"31","author":"Erdemir","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1022434406400","article-title":"Specific [3H]glutamate binding in the cerebral cortex and hippocampus of rats during development: effect of homocysteine-induced seizures","volume":"22","author":"Folbergrov\u00e1","year":"1997","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eplepsyres.2005.03.005","article-title":"Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy","volume":"64","author":"Gidal","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1528-1167.2008.01967.x","article-title":"Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report","volume":"50","author":"Gorgone","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2010.11.031","article-title":"Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population","volume":"214","author":"Gu\u00e9ant-Rodriguez","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajmg.1247","article-title":"Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype","volume":"100","author":"Guttormsen","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1254\/jphs.CRJ05003X","article-title":"The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins","volume":"98","author":"Hamed","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00019052-200102000-00015","article-title":"Homocysteine and stroke","volume":"14","author":"Hankey","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0165","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0170","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic)","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0175","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(11)60872-6","article-title":"Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials","volume":"378","author":"Holmes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0180","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1528-1167.2005.00264.x","article-title":"Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation","volume":"46","author":"Huemer","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2741\/s70","volume":"2","author":"Ientile","year":"2010","journal-title":"Front Biosci. (Schol Ed)"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0190","series-title":"Dietary Reference Intakes for Thiamine, Riboflavin Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline","article-title":"Folate","author":"Institute of Medicine","year":"1998"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1528-1157.1988.tb03746.x","article-title":"Teratogenicity of antiepileptic drugs: analysis of possible risk factors","volume":"29","author":"Kaneko","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(02)00163-8","article-title":"Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid","volume":"25","author":"Karabiber","year":"2003","journal-title":"Brain Dev."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0205","first-page":"208","article-title":"Folates: supplemental forms and therapeutic applications","volume":"3","author":"Kelly","year":"1998","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(96)00256-0","article-title":"Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy","volume":"145","author":"Kishi","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0225","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.22229","article-title":"Antiepileptic drugs interact with folate and vitamin B12 serum levels","volume":"69","author":"Linnebank","year":"2011","journal-title":"Ann. Neurol."},{"issue":"March","key":"10.1016\/j.eplepsyres.2012.07.003_bib0230","article-title":"Antiepileptic drugs and vitamin B6 plasma levels in adult patients","author":"Linnebank","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0235","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/00365519950185878","article-title":"Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate","volume":"59","author":"Mansoor","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0250","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2012.04.132","article-title":"B-Vitamin deficiency in patients treated with antiepileptic drugs","volume":"24","author":"Mintzer","year":"2012","journal-title":"Epilepsy & Behav."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0260","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/01.wnl.0000179177.15900.ca","article-title":"Retinal microvascular signs and risk of stroke and stroke mortality","volume":"65","author":"Mitchell","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1535-7597.2002.00017.x","article-title":"Folic acid and epilepsy","volume":"2","author":"Morrell","year":"2002","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0270","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2008.156109","article-title":"Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"80","author":"Morrow","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/gps.388","article-title":"Improvement of cognitive functions after cobalamin\/folate supplementation in elderly patients with dementia and elevated plasma homocysteine","volume":"16","author":"Nilsson","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0920-1211(91)90039-I","article-title":"Serum folic acid levels in epileptic mothers and their relationship to congenital malformations","volume":"8","author":"Ogawa","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0285","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jama.281.13.1189","article-title":"Distribution of and factors associated with serum homocysteine levels in children: child and adolescent trial for cardiovascular health","volume":"281","author":"Osganian","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eplepsyres.2009.07.011","article-title":"Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?","volume":"87","author":"Oz","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0295","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00431-010-1366-5","article-title":"Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid","volume":"170","author":"Ozdemir","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00726-006-0432-9","article-title":"Mechanisms of homocysteine toxicity in humans","volume":"32","author":"Perla-Kaj\u00e0n","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0305","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1012592","article-title":"Carotid-wall intima-media thickness and cardiovascular events","volume":"365","author":"Polak","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/brain\/91.2.197","article-title":"Mental effects of anticonvulsants, and folic acid metabolism","volume":"91","author":"Reynolds","year":"1968","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0315","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(73)91690-5","article-title":"Anticonvulsants, folic acid and epilepsy","volume":"1","author":"Reynolds","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0320","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0325","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0038-1657581","article-title":"Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR)","volume":"78","author":"Rozen","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0330","first-page":"30","article-title":"Too much folate: a risk factor for cancer and cardiovascular disease?","volume":"12","author":"Sauer","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1528-1157.1999.tb00716.x","article-title":"Elevated plasma concentrations of homocysteine in antiepileptic drug treatment","volume":"40","author":"Schwaninger","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0340","doi-asserted-by":"crossref","unstructured":"SEARCH Collaborative Group, 2010. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 303, 2486\u20132494.","DOI":"10.1001\/jama.2010.840"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0345","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.seizure.2011.04.001","article-title":"MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs","volume":"20","author":"Sniezawska","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0350","first-page":"45","article-title":"Comparison of oral folic acid and folinic acid on blood homocysteine level of patients on hemodialysis","volume":"5","author":"Soleimani","year":"2011","journal-title":"Iran J. Kidney Dis."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0355","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(07)70219-3","article-title":"Homocysteine-lowering therapy: a role in stroke prevention?","volume":"6","author":"Spence","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(95)05748-X","article-title":"Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria","volume":"132","author":"Tsai","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0365","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0140-6736(01)07229-4","article-title":"Importance of asymmetric dimethylarginine in cardiovascular risk","volume":"358","author":"Vallance","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0370","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0920-1211(00)00150-9","article-title":"Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine","volume":"41","author":"Verrotti","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","article-title":"A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity","volume":"64","author":"Weisberg","year":"1998","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0380","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(00)00671-7","article-title":"The 1298A3C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine","volume":"156","author":"Weisberg","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.eplepsyres.2012.07.003_bib0385","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-150-9-200905050-00010","article-title":"Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force","volume":"150","author":"Wolff","year":"2009","journal-title":"Ann. Intern. Med."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:27:30Z","timestamp":1760275650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":77,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0920121112001829"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.07.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}